S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:MRVI

Maravai LifeSciences Stock Forecast, Price & News

$35.59
+1.52 (+4.46 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$31.75
Now: $35.59
$35.62
50-Day Range
$27.77
MA: $33.11
$36.47
52-Week Range
$23.62
Now: $35.59
$40.24
Volume1.48 million shs
Average Volume1.25 million shs
Market Capitalization$6.00 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry. The company serves biopharmaceutical companies, and other emerging biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
Maravai LifeSciences logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MRVI
CUSIPN/A
CIKN/A
Phone858 546 0004
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$6.00 billion
Next Earnings Date6/1/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.88 out of 5 stars

Medical Sector

54th out of 1,972 stocks

Pharmaceutical Preparations Industry

19th out of 772 stocks

Analyst Opinion: 2.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$35.59
+1.52 (+4.46 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MRVI News and Ratings via Email

Sign-up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Maravai LifeSciences (NASDAQ:MRVI) Frequently Asked Questions

Is Maravai LifeSciences a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maravai LifeSciences in the last twelve months. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Maravai LifeSciences stock.
View analyst ratings for Maravai LifeSciences
or view top-rated stocks.

What stocks does MarketBeat like better than Maravai LifeSciences?

Wall Street analysts have given Maravai LifeSciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Maravai LifeSciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Maravai LifeSciences' next earnings date?

Maravai LifeSciences is scheduled to release its next quarterly earnings announcement on Tuesday, June 1st 2021.
View our earnings forecast for Maravai LifeSciences
.

How were Maravai LifeSciences' earnings last quarter?

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) released its quarterly earnings results on Monday, March, 1st. The company reported $0.13 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.11 by $0.02.
View Maravai LifeSciences' earnings history
.

What guidance has Maravai LifeSciences issued on next quarter's earnings?

Maravai LifeSciences updated its FY21 earnings guidance on Tuesday, March, 2nd. The company provided EPS guidance of $0.80-$0.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.60. The company issued revenue guidance of $580-$630 million, compared to the consensus revenue estimate of $429.55 million.

What price target have analysts set for MRVI?

10 Wall Street analysts have issued 12-month price targets for Maravai LifeSciences' stock. Their forecasts range from $31.00 to $54.00. On average, they expect Maravai LifeSciences' stock price to reach $37.13 in the next year. This suggests a possible upside of 4.3% from the stock's current price.
View analysts' price targets for Maravai LifeSciences
or view top-rated stocks among Wall Street analysts.

Who are Maravai LifeSciences' key executives?

Maravai LifeSciences' management team includes the following people:
  • Mr. Carl W. Hull, Partner, Co-Founder, CEO & Chairman (Age 62)
  • Mr. Eric X. Tardif, Partner, Co-Founder & Pres (Age 51)
  • Mr. Kevin M. Herde, VP & CFO (Age 49)
  • Mr. Kurt Oreshack, Gen. Counsel (Age 41)
  • Ms. Christine Dolan, Chief Operating Officer of Biologics Safety Testing (Age 53)
  • Mr. Brian Neel, Chief Operating Officer of Nucleic Acid Production (Age 45)
  • Ms. Lisa Sellers, Chief Operating Officer of Protein Detection (Age 49)

Who are some of Maravai LifeSciences' key competitors?

When did Maravai LifeSciences IPO?

(MRVI) raised $1.3 billion in an initial public offering (IPO) on Friday, November 20th 2020. The company issued 50,000,000 shares at $24.00-$27.00 per share. Morgan Stanley, Jefferies and Goldman Sachs acted as the underwriters for the IPO and BofA Securities, Credit Suisse, UBS Investment Bank, Baird, William Blair, Stifel, Keybanc Securities, Academy Securities, Loop Capital Markets, Penserra Securities and Tigress Financial Partners were co-managers.

What is Maravai LifeSciences' stock symbol?

Maravai LifeSciences trades on the NASDAQ under the ticker symbol "MRVI."

When does the company's lock-up period expire?

Maravai LifeSciences' lock-up period expires on Wednesday, May 19th. Maravai LifeSciences had issued 60,000,000 shares in its IPO on November 20th. The total size of the offering was $1,620,000,000 based on an initial share price of $27.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Who are Maravai LifeSciences' major shareholders?

Maravai LifeSciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Gtcr LLC (16.39%), D1 Capital Partners L.P. (3.52%), JPMorgan Chase & Co. (2.46%), UBS Asset Management Americas Inc. (2.23%), Avidity Partners Management LP (2.04%) and Lazard Asset Management LLC (2.03%).

Which institutional investors are buying Maravai LifeSciences stock?

MRVI stock was acquired by a variety of institutional investors in the last quarter, including Gtcr LLC, D1 Capital Partners L.P., JPMorgan Chase & Co., UBS Asset Management Americas Inc., Avidity Partners Management LP, Lazard Asset Management LLC, BlackRock Inc., and Clearbridge Investments LLC.

How do I buy shares of Maravai LifeSciences?

Shares of MRVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maravai LifeSciences' stock price today?

One share of MRVI stock can currently be purchased for approximately $35.59.

How much money does Maravai LifeSciences make?

Maravai LifeSciences has a market capitalization of $6.00 billion.

What is Maravai LifeSciences' official website?

The official website for Maravai LifeSciences is www.maravai.com.

Where are Maravai LifeSciences' headquarters?

Maravai LifeSciences is headquartered at 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO CA, 92121.

How can I contact Maravai LifeSciences?

Maravai LifeSciences' mailing address is 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO CA, 92121. The company can be reached via phone at 858 546 0004 or via email at [email protected]


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.